461 related articles for article (PubMed ID: 24524730)
1. Assessment of pancreatic β-cell function: review of methods and clinical applications.
Cersosimo E; Solis-Herrera C; Trautmann ME; Malloy J; Triplitt CL
Curr Diabetes Rev; 2014 Jan; 10(1):2-42. PubMed ID: 24524730
[TBL] [Abstract][Full Text] [Related]
2. DPP-4 inhibitor treatment: β-cell response but not HbA
Kozlovski P; Bhosekar V; Foley JE
Vasc Health Risk Manag; 2017; 13():123-126. PubMed ID: 28408838
[TBL] [Abstract][Full Text] [Related]
3. GLP-1 receptor activated insulin secretion from pancreatic β-cells: mechanism and glucose dependence.
Meloni AR; DeYoung MB; Lowe C; Parkes DG
Diabetes Obes Metab; 2013 Jan; 15(1):15-27. PubMed ID: 22776039
[TBL] [Abstract][Full Text] [Related]
4. Effects of saxagliptin on β-cell stimulation and insulin secretion in patients with type 2 diabetes.
Henry RR; Smith SR; Schwartz SL; Mudaliar SR; Deacon CF; Holst JJ; Duan RY; Chen RS; List JF
Diabetes Obes Metab; 2011 Sep; 13(9):850-8. PubMed ID: 21554520
[TBL] [Abstract][Full Text] [Related]
5. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
6. Restoration of the insulinotropic effect of glucose-dependent insulinotropic polypeptide contributes to the antidiabetic effect of dipeptidyl peptidase-4 inhibitors.
Aaboe K; Akram S; Deacon CF; Holst JJ; Madsbad S; Krarup T
Diabetes Obes Metab; 2015 Jan; 17(1):74-81. PubMed ID: 25243647
[TBL] [Abstract][Full Text] [Related]
7. Addition of sitagliptin or metformin to insulin monotherapy improves blood glucose control via different effects on insulin and glucagon secretion in hyperglycemic Japanese patients with type 2 diabetes.
Otsuka Y; Yamaguchi S; Furukawa A; Kosuda M; Nakazaki M; Ishihara H
Endocr J; 2015; 62(2):133-43. PubMed ID: 25328079
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of incretin based therapies: clinical trial data.
White J
J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S30-40. PubMed ID: 19801363
[TBL] [Abstract][Full Text] [Related]
9. The effects of incretin-based therapies on β-cell function and insulin resistance in type 2 diabetes: A systematic review and network meta-analysis combining 360 trials.
Wu S; Gao L; Cipriani A; Huang Y; Yang Z; Yang J; Yu S; Zhang Y; Chai S; Zhang Z; Sun F; Zhan S
Diabetes Obes Metab; 2019 Apr; 21(4):975-983. PubMed ID: 30536884
[TBL] [Abstract][Full Text] [Related]
10. Dipeptidyl-Peptidase-IV Inhibitors, Imigliptin and Alogliptin, Improve Beta-Cell Function in Type 2 Diabetes.
Liu X; Liu Y; Liu H; Li H; Yang J; Hu P; Xiao X; Liu D
Front Endocrinol (Lausanne); 2021; 12():694390. PubMed ID: 34616361
[TBL] [Abstract][Full Text] [Related]
11. Incretins: their physiology and application in the treatment of diabetes mellitus.
Tasyurek HM; Altunbas HA; Balci MK; Sanlioglu S
Diabetes Metab Res Rev; 2014 Jul; 30(5):354-71. PubMed ID: 24989141
[TBL] [Abstract][Full Text] [Related]
12. Determining pancreatic β-cell compensation for changing insulin sensitivity using an oral glucose tolerance test.
Solomon TP; Malin SK; Karstoft K; Knudsen SH; Haus JM; Laye MJ; Pedersen M; Pedersen BK; Kirwan JP
Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E822-9. PubMed ID: 25184989
[TBL] [Abstract][Full Text] [Related]
13. Standardized Mixed-Meal Tolerance and Arginine Stimulation Tests Provide Reproducible and Complementary Measures of β-Cell Function: Results From the Foundation for the National Institutes of Health Biomarkers Consortium Investigative Series.
Shankar SS; Vella A; Raymond RH; Staten MA; Calle RA; Bergman RN; Cao C; Chen D; Cobelli C; Dalla Man C; Deeg M; Dong JQ; Lee DS; Polidori D; Robertson RP; Ruetten H; Stefanovski D; Vassileva MT; Weir GC; Fryburg DA;
Diabetes Care; 2016 Sep; 39(9):1602-13. PubMed ID: 27407117
[TBL] [Abstract][Full Text] [Related]
14. Discriminatory ability of simple OGTT-based beta cell function indices for prediction of prediabetes and type 2 diabetes: the CODAM study.
den Biggelaar LJ; Sep SJ; Eussen SJ; Mari A; Ferrannini E; van Greevenbroek MM; van der Kallen CJ; Schalkwijk CG; Stehouwer CD; Dagnelie PC
Diabetologia; 2017 Mar; 60(3):432-441. PubMed ID: 27933333
[TBL] [Abstract][Full Text] [Related]
15. Saxagliptin improves glycemic control by modulating postprandial glucagon and C-peptide levels in Chinese patients with type 2 diabetes.
Sjöstrand M; Iqbal N; Lu J; Hirshberg B
Diabetes Res Clin Pract; 2014 Aug; 105(2):185-91. PubMed ID: 24947443
[TBL] [Abstract][Full Text] [Related]
16. Roux-en-Y gastric bypass-induced improvement of glucose tolerance and insulin resistance in type 2 diabetic rats are mediated by glucagon-like peptide-1.
Liu Y; Zhou Y; Wang Y; Geng D; Liu J
Obes Surg; 2011 Sep; 21(9):1424-31. PubMed ID: 21479766
[TBL] [Abstract][Full Text] [Related]
17. Associations of β-cell function and insulin resistance with youth-onset type 2 diabetes and prediabetes among Asian Indians.
Mohan V; Amutha A; Ranjani H; Unnikrishnan R; Datta M; Anjana RM; Staimez L; Ali MK; Narayan KM
Diabetes Technol Ther; 2013 Apr; 15(4):315-22. PubMed ID: 23484483
[TBL] [Abstract][Full Text] [Related]
18. Restoring Insulin Secretion (RISE): design of studies of β-cell preservation in prediabetes and early type 2 diabetes across the life span.
RISE Consortium
Diabetes Care; 2014; 37(3):780-8. PubMed ID: 24194506
[TBL] [Abstract][Full Text] [Related]
19. Postprandial serum C-peptide to plasma glucose concentration ratio correlates with oral glucose tolerance test- and glucose clamp-based disposition indexes.
Okuno Y; Komada H; Sakaguchi K; Nakamura T; Hashimoto N; Hirota Y; Ogawa W; Seino S
Metabolism; 2013 Oct; 62(10):1470-6. PubMed ID: 23831440
[TBL] [Abstract][Full Text] [Related]
20. Differential importance of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide 1 receptor signaling for beta cell survival in mice.
Maida A; Hansotia T; Longuet C; Seino Y; Drucker DJ
Gastroenterology; 2009 Dec; 137(6):2146-57. PubMed ID: 19766644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
